MarkDLineberryMD

Cardiology • Paducah, KY

Adult Congenital Heart Disease, Cardiac Electrophysiology

Physician

Join to view full profile

Dr. Lineberry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lineberry's full profile

Already have an account?

Office
1532 Lone Oak Rd
Suite 415
Paducah, KY 42003
Phone+1 270-442-0103

Fax+1 270-442-0109
Is this information wrong?

Education & Training

Vanderbilt University Medical CenterFellowship, Cardiovascular Disease, 1986 - 1988
University of Louisville School of MedicineResidency, Internal Medicine, 1982 - 1985
University of Louisville School of MedicineClass of 1982

Certifications & Licensure

KY State Medical License 1983 - 2025
TN State Medical License 1985 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

1 citations
Prospective pharmacokinetically based development of effective infusion regimens for ACC-9358, a new antiarrhythmic drug.
Harris N Pavlou, Christian Funck-Brentano, Mark D. Lineberry, Raymond L. Woosley, Dan M. Roden> ;Clinical Pharmacology and Therapeutics. 1991 Mar 1
91 citations
The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone.
John T. Lee, Heyo K. Kroemer, David J. Silberstein, Christian Funck-Brentano, Mark D. Lineberry, Alastair J. J. Wood, Dan M. Roden, Raymond L. Woosley> ;The New England Journal of Medicine. 1990 Jun 21
25 citations
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.
Katherine T. Murray, C. S. Reilly, Richard P. Koshakji, Dan M. Roden, Mark D. Lineberry, Alastair J. J. Wood, Lyle A. Siddoway, Jean T. Barbey, Raymond L. Woosley> ;The Journal of Clinical Investigation. 1990 Mar 1
5 citations
Recainam dose titration and pharmacokinetics in patients with resistant arrhythmias.
Richard F Davies, Mark D. Lineberry, Christian Funck-Brentano, Debra S. Echt, John T. Lee, David M Capuzzi, Dan M. Roden, Raymond L. Woosley> ;Clinical Pharmacology and Therapeutics. 1989 Sep 1
14 citations
Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
Christian Funck-Brentano, Richard T. Light, Mark D. Lineberry, Gisela M. Wright, Dan M. Roden, Raymond L. Woosley> ;Journal of Cardiovascular Pharmacology. 1989 Sep 1
Carbonic anhydrase, cyclic AMP, and the phosphaturia of parathyroid hormone.
Mark D. Lineberry, Leonard C. Waite> ;Biochemical Medicine. 1978 Oct 1
Calcitonin responses in intact and adrenalectomized rats.
Mark D. Lineberry, Leonard C. Waite> ;Life Sciences. 1978 Feb 1
Effect of sulfonamides on the hypercalcemic response to vitamin D.
Pierce, W. M., Lineberry, M. D., Waite, L. C.> ;Horm Metab Res. 1982 Dec
Sulfonamide inhibition of bone resorption: lack of a hypophosphatemia.
Waite, L. C., Pierce, W. M., Lineberry, M. D.> ;J Pharmacol Exp Ther. 1980 Jun
Hypocalcemic effect of phentolamine.
Waite, L. C., Lineberry, M. D.> ;Res Commun Chem Pathol Pharmacol. 1978 Mar
Acidosis inhibits the hypocalcemic effect of acetazolamide.
Lineberry, M. D., Waite, L. C.> ;J Pharmacol Exp Ther. 1979 Dec
Join now to see all